Complementary Acupuncture Treatment of Dysphagia in Stroke

Sponsor
China Medical University Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05429424
Collaborator
(none)
315
3
36

Study Details

Study Description

Brief Summary

A Taiwanese study pointed out that stroke patients who have language barriers, dysphagia, and aspiration pneumonia are more likely to suffer from prolonged hospitalization. Improvements in dysphagia and subsequent complications in patients should be effective in reducing hospital stays and improving the quality of long-term care. In view of clinical medical needs and policy trends, this study aims to explore the efficacy of using traditional Chinese medicine to treat cerebral apoplexy sequelae in Taiwan. It is expected that through (1) exploration of real-world data analysis, combined with the advantages of Taiwan's biomedical database, data exploration will be carried out to provide big data (2) Multi-center prospective randomized clinical trials, providing clinical evidence of the highest level of evidence in empirical medicine.

Condition or Disease Intervention/Treatment Phase
  • Other: Verum acupuncture group
  • Other: Sham control group I
  • Other: Sham control group II
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
315 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Masking Description:
In this study, the participants, assessor, and statistician are all blinded to the treatment assignments except for the acupuncturist and study coordinator.
Primary Purpose:
Treatment
Official Title:
Complementary Acupuncture Treatment of Dysphagia in Stroke
Anticipated Study Start Date :
Aug 1, 2022
Anticipated Primary Completion Date :
Jul 31, 2025
Anticipated Study Completion Date :
Jul 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Verum acupuncture group

The study uses manual acupuncture as verum intervention.

Other: Verum acupuncture group
The acupuncturist disinfected the skin of the selected acupoints with alcohol, then vertically penetrated the skin with disposable stainless-steel needles (size, brand, Taiwan) to the depth predetermined for each point (between 8-25 mm, depending on the location of the acupoint) and achieved a "deqi" response, often described as a pressure, fullness, or achiness feeling around the acupoints.

Sham Comparator: Sham control group I

The study used specific made needle with a blunt tip, Streitberger device, as sham intervention.

Other: Sham control group I
The needle does not penetrate the skin and retract in the handle while the acupuncturist needling into the skin. The participants easily believe their intervention owing to the sensation of needling into the skin that the device mimics. The needles were fixed with a plastic ring and micropore on the body of the participants without manipulation.

Sham Comparator: Sham control group II

Manual acupuncture at the points unrelated to the dysphagia is another sham intervention in this study.

Other: Sham control group II
The acupuncturist disinfected the skin of the selected acupoints with alcohol, then vertically penetrated the skin with disposable stainless-steel needles (size, brand, Taiwan) to the depth predetermined for each point (between 8-25 mm, depending on the location of the acupoint) and achieved a "deqi" response, often described as a pressure, fullness, or achiness feeling around the acupoints.

Outcome Measures

Primary Outcome Measures

  1. dysphagia severity rating scale (DSRS) [baseline, the 2nd week of the intervention, 1st and 4th week of follow-up period]

    dysphagia severity rating scale(DSRS) indicates the feeding status of the dysphagia patient in three subdomains: fluids, diet, and level of supervision required for feeding. The total score from 0 to 12. The higher scores means the better outcome. Changes from baseline to the 2nd week of the intervention, the 1st and 4th week of follow-up period.

  2. the functional oral intake scale (FOIS) [baseline, the 2nd week of the intervention, 1st and 4th week of follow-up period]

    the functional oral intake scale(FOIS) is used to assessing the functional level of oral intake of food and liquid in stroke patients. It is a 7-point scale, with level 1 indicating complete impairment of oral intake, and level 7 indicating complete oral intake regardless of food consistency or type. Changes from baseline to the 2nd week of the intervention, the 1st and 4th week of follow-up period.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • .Patients aged more than 20 years

  • The diagnosis of first stroke was established within the six months

  • Patients had a score ≥ 25 of Mini-Mental State Examination (MMSE)

  • Patients met one or both indications as follows

  1. Dysphagia confirmed under the standardized swallowing assessment

  2. Nasogastric tube feeding already

Exclusion Criteria:
  • Previous history of swallowing disability

  • Currently known coagulopathy leading to bleeding disorder.

  • Previous surgery of head or neck

  • Local infection at or near the acupuncture site is not suitable for acupuncture after physician examination.

  • Psychological or behavior disorder

  • Currently pregnant or breastfeeding women.

  • Previous acupuncture treatment for any indication within 30 days of enrollment.

  • Severe chronic or uncontrollable complications interference the processing of the trial

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • China Medical University Hospital

Investigators

  • Study Chair: China Medicine University China Medicine University, China Medicine University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
China Medical University Hospital
ClinicalTrials.gov Identifier:
NCT05429424
Other Study ID Numbers:
  • CMUH111-REC1-065
First Posted:
Jun 23, 2022
Last Update Posted:
Jun 23, 2022
Last Verified:
Jun 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by China Medical University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 23, 2022